Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CBRG
CBRG logo

CBRG Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
12.235
Open
12.235
VWAP
10.46
Vol
5.64M
Mkt Cap
76.46M
Low
9.310
Amount
58.98M
EV/EBITDA(TTM)
--
Total Shares
--
EV
69.61M
EV/OCF(TTM)
--
P/S(TTM)
--
Chain Bridge I is a blank check company. The Company is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It intends to focus its efforts in identifying a prospective target company possessing emerging, innovative technology that can help the United States (U.S) government and its allies compete in the national security arena. It intends to focus for companies in various areas, including artificial intelligence and machine learning, autonomous systems; bio-defense, biomaterials and biotechnology; security, particularly cybersecurity; digital intelligence and data; intelligent connectivity; microelectronics, and trusted infrastructure. It has no operations and has generated no revenues.
Show More

Events Timeline

No data

No data

News

Newsfilter
8.4
2024-07-22Newsfilter
Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines
  • Phytanix Bio and Chain Bridge I Merger: Phytanix Bio, a preclinical pharmaceutical company focused on cannabinoid-based medicines, has announced a merger with Chain Bridge I (CBRG), valuing the combined entity at approximately $58 million, with plans to list on Nasdaq under the ticker "PHYX" by Q4 2024.

  • Leadership and Drug Development Focus: The new company will be led by experienced executives from Phytanix Bio, aiming to advance innovative cannabinoid therapies for conditions like treatment-resistant facial seizures and Painful Bladder Syndrome, leveraging their extensive expertise in drug development and intellectual property.

SeekingAlpha
8.4
2024-07-22SeekingAlpha
Chain Bridge I to buy Phytanix Bio
  • Business Combination Announcement: Phytanix Bio and Chain Bridge I have entered into a definitive agreement for a business combination, expected to close in Q4 2024, with Phytanix anticipated to receive up to $11M in cash from CBRG's trust.

  • Leadership and Future Plans: The combined entity will be named Phytanix, listed on Nasdaq under the ticker “PHYX,” and will be led by Phytanix Bio’s founders, with Barrett Evans serving as CEO.

Wall Street analysts forecast CBRG stock price to rise
0 Analyst Rating
Wall Street analysts forecast CBRG stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Chain Bridge I (CBRG.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Chain Bridge I's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding CBRG

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Chain Bridge I (CBRG) stock price today?

The current price of CBRG is 9.84 USD — it has decreased -18.68

What is Chain Bridge I (CBRG)'s business?

Chain Bridge I is a blank check company. The Company is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It intends to focus its efforts in identifying a prospective target company possessing emerging, innovative technology that can help the United States (U.S) government and its allies compete in the national security arena. It intends to focus for companies in various areas, including artificial intelligence and machine learning, autonomous systems; bio-defense, biomaterials and biotechnology; security, particularly cybersecurity; digital intelligence and data; intelligent connectivity; microelectronics, and trusted infrastructure. It has no operations and has generated no revenues.

What is the price predicton of CBRG Stock?

Wall Street analysts forecast CBRG stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBRG is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Chain Bridge I (CBRG)'s revenue for the last quarter?

Chain Bridge I revenue for the last quarter amounts to -451.66K USD, increased 73.55

What is Chain Bridge I (CBRG)'s earnings per share (EPS) for the last quarter?

Chain Bridge I. EPS for the last quarter amounts to -149471.00 USD, decreased -59.30

How many employees does Chain Bridge I (CBRG). have?

Chain Bridge I (CBRG) has 2 emplpoyees as of May 25 2026.

What is Chain Bridge I (CBRG) market cap?

Today CBRG has the market capitalization of 76.46M USD.